GSH deficiency results in the activation of von Willebrand Factor (Ibrahim et al., 2004) and in the accumulation of ROS, which affect clotting and platelet activation, impair endothelial function, and predispose to the risk of thrombotic events (Violi et al., 2017): notably, hypercoagulation is a prominent life-threatening complication in COVID-19 patients (Giardini et al., 2020)
A note on dosage: The Salehpour study used 3,000 mg/day
It can aid in healing of damaged tissues, enhance recovery and control inflammation via various pathways
Research indicates BPC-157 significantly enhances cell survival under oxidative stress conditions (H2O2 exposure), protecting fibroblasts during the inflammatory phase of healing when reactive oxygen species are elevated
10.1111/j.2042-7158.1997.tb06822.x
In the current study, depriving RPE cells of the essential GSH precursor Cys 2 by culturing cells in Cys 2 -free culture medium or blocking de novo synthesis of GSH by using GCL inhibitor BSO or blocking Cys 2 uptake by pharmaceutical inhibition of system x c caused cell death